Patient safety is the absolute priority at New Blue Health. Our safety protocols are designed to go beyond the standard of care for online healthcare, ensuring that every patient's therapeutic journey is both effective and clinically responsible. We believe that peptide therapy, while powerful, must be approached with professional oversight and a rigorous screening process.
Our Safety Framework
1. Rigorous Clinical Screening: Every patient must complete a comprehensive medical intake. Our licensed clinicians review personal health history, current medications, and specific risk factors for contraindications before any treatment is initiated.
2. Monitoring and Follow-up: Treatment is not a one-time event. We provide structured protocols for monitoring patient progress and potential side effects, with easy access to our clinical team for questions or adjustments.
3. Emergency Referral Protocol: While our services are optimized for wellness and longevity, we maintain clear protocols for identifying and referring patients to local emergency care or specialists if a serious health issue is detected.
Contraindication Review
Certain conditions may make specific peptide pathways unsafe for some individuals. For example, patients with a history of certain types of thyroid cancer or pancreatitis are generally excluded from GLP-1 pathways. Our clinicians are trained to identify these high-risk profiles during the intake process.
We encourage all patients to maintain a relationship with a local primary care physician (PCP) and to share their New Blue Health treatment plans with them to ensure continuity of care. See our Medical Review Policy.